DocGo Inc. (NASDAQ:DCGO) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of DocGo Inc. (NASDAQ:DCGO) have been assigned an average recommendation of “Moderate Buy” from the six analysts that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $4.89.

A number of analysts recently issued reports on DCGO shares. Deutsche Bank Aktiengesellschaft cut DocGo from a “buy” rating to a “hold” rating and lowered their target price for the stock from $5.00 to $2.85 in a research note on Friday, February 28th. Needham & Company LLC decreased their price target on shares of DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research note on Friday, February 28th. Finally, Stifel Nicolaus cut their price objective on DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a report on Friday, February 28th.

DocGo Stock Performance

NASDAQ DCGO opened at $2.93 on Friday. The business has a 50 day simple moving average of $4.51 and a 200 day simple moving average of $4.01. DocGo has a 52-week low of $2.75 and a 52-week high of $5.68. The stock has a market cap of $299.01 million, a price-to-earnings ratio of 10.46, a PEG ratio of 14.16 and a beta of 1.00.

Insider Buying and Selling at DocGo

In other DocGo news, General Counsel Ely D. Tendler sold 23,088 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the sale, the general counsel now owns 175,645 shares of the company’s stock, valued at $779,863.80. This trade represents a 11.62 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in DCGO. Centiva Capital LP bought a new position in DocGo during the 3rd quarter worth $43,000. Summit Investment Advisors Inc. increased its position in DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock worth $45,000 after buying an additional 2,968 shares during the period. Prudential Financial Inc. bought a new position in DocGo during the 4th quarter worth $55,000. Intech Investment Management LLC bought a new position in DocGo during the 3rd quarter worth $62,000. Finally, Royce & Associates LP bought a new position in DocGo during the 4th quarter worth $64,000. Institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.